First National Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.21M | Sell |
12,629
-1
| -0% | -$543 | 0.21% | 105 |
|
|
2025
Q4 | $7.32M | Buy |
12,630
+318
| +3% | +$180K | 0.24% | 91 |
|
|
2025
Q3 | $5.97M | Sell |
12,312
-743
| -6% | -$346K | 0.2% | 105 |
|
|
2025
Q2 | $5.29M | Sell |
13,055
-68
| -0.5% | -$28.4K | 0.2% | 107 |
|
|
2025
Q1 | $6.53M | Sell |
13,123
-375
| -3% | -$203K | 0.26% | 94 |
|
|
2024
Q4 | $7.02M | Buy |
13,498
+210
| +2% | +$115K | 0.26% | 87 |
|
|
2024
Q3 | $8.22M | Sell |
13,288
-99
| -0.7% | -$58.6K | 0.32% | 74 |
|
|
2024
Q2 | $7.4M | Sell |
13,387
-383
| -3% | -$219K | 0.3% | 76 |
|
|
2024
Q1 | $8M | Sell |
13,770
-195
| -1% | -$109K | 0.33% | 76 |
|
|
2023
Q4 | $7.41M | Sell |
13,965
-1,168
| -8% | -$565K | 0.33% | 79 |
|
|
2023
Q3 | $7.66M | Sell |
15,133
-223
| -1% | -$119K | 0.37% | 74 |
|
|
2023
Q2 | $8.01M | Buy |
15,356
+1,791
| +13% | +$966K | 0.37% | 74 |
|
|
2023
Q1 | $7.82M | Sell |
13,565
-334
| -2% | -$188K | 0.42% | 74 |
|
|
2022
Q4 | $7.65M | Sell |
13,899
-25
| -0.2% | -$13.2K | 0.4% | 74 |
|
|
2022
Q3 | $7.06M | Sell |
13,924
-414
| -3% | -$232K | 0.41% | 75 |
|
|
2022
Q2 | $7.79M | Buy |
14,338
+266
| +2% | +$146K | 0.44% | 68 |
|
|
2022
Q1 | $8.31M | Buy |
14,072
+515
| +4% | +$296K | 0.43% | 74 |
|
|
2021
Q4 | $9.04M | Buy |
13,557
+1,290
| +11% | +$805K | 0.48% | 65 |
|
|
2021
Q3 | $7.01M | Buy |
12,267
+124
| +1% | +$68.1K | 0.42% | 76 |
|
|
2021
Q2 | $6.13M | Buy |
12,143
+248
| +2% | +$117K | 0.37% | 87 |
|
|
2021
Q1 | $5.43M | Buy |
11,895
+367
| +3% | +$175K | 0.36% | 87 |
|
|
2020
Q4 | $5.37M | Buy |
11,528
+576
| +5% | +$270K | 0.37% | 83 |
|
|
2020
Q3 | $4.84M | Buy |
10,952
+7
| +0.1% | +$2.89K | 0.38% | 77 |
|
|
2020
Q2 | $3.97M | Sell |
10,945
-260
| -2% | -$87.1K | 0.34% | 85 |
|
|
2020
Q1 | $3.18M | Sell |
11,205
-5,335
| -32% | -$1.68M | 0.32% | 85 |
|
|
2019
Q4 | $5.37M | Buy |
16,540
+311
| +2% | +$94.3K | 0.44% | 68 |
|
|
2019
Q3 | $4.73M | Sell |
16,229
-536
| -3% | -$153K | 0.42% | 74 |
|
|
2019
Q2 | $4.92M | Sell |
16,765
-11,414
| -41% | -$3.14M | 0.46% | 65 |
|
|
2019
Q1 | $7.71M | Buy |
28,179
+1,543
| +6% | +$384K | 0.77% | 41 |
|
|
2018
Q4 | $5.96M | Buy |
26,636
+5,094
| +24% | +$1.2M | 0.66% | 48 |
|
|
2018
Q3 | $5.26M | Buy |
21,542
+1,367
| +7% | +$314K | 0.54% | 54 |
|
|
2018
Q2 | $4.18M | Buy |
20,175
+1,849
| +10% | +$392K | 0.46% | 64 |
|
|
2018
Q1 | $3.78M | Buy |
18,326
+13,429
| +274% | +$2.82M | 0.43% | 74 |
|
|
2017
Q4 | $930K | Buy |
4,897
+1,239
| +34% | +$237K | 0.1% | 185 |
|
|
2017
Q3 | $692K | Buy |
3,658
+363
| +11% | +$65.7K | 0.08% | 198 |
|
|
2017
Q2 | $575K | Sell |
3,295
-545
| -14% | -$91.5K | 0.07% | 218 |
|
|
2017
Q1 | $590K | Sell |
3,840
-948
| -20% | -$145K | 0.08% | 206 |
|
|
2016
Q4 | $676K | Buy |
4,788
+728
| +18% | +$107K | 0.1% | 189 |
|
|
2016
Q3 | $645K | Buy |
4,060
+1,945
| +92% | +$300K | 0.1% | 179 |
|
|
2016
Q2 | $313K | Buy |
+2,115
| New | +$312K | 0.05% | 232 |
|
Other funds holding TMO
VCM
First National Trust's TMO Position: Q1 2026 in Review
First National Trust reduced its Thermo Fisher Scientific (TMO) stake by 0.01% in Q1 2026, selling an estimated $543 and leaving 12,629 shares worth $6.21M. The position accounts for 0.21% of the portfolio, ranked #105.
First National Trust first reported a position in TMO in Q2 2016 and has held it in 40 quarters since. The position peaked at $9.04M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- First National Trust held 12,629 shares of Thermo Fisher Scientific worth $6.21M as of Q1 2026.
- First National Trust sold 1 Thermo Fisher Scientific share in Q1 2026, an estimated $543.
- Thermo Fisher Scientific made up 0.21% of First National Trust's portfolio in Q1 2026, its #105 holding.
- First National Trust first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 40 quarters since.
- First National Trust's Thermo Fisher Scientific position peaked at $9.04M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.